Juan Shi Selected Research

Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)

4/2020	[Effects of Long Non-coding RNA Plasmacytoma Variant Translocation 1 Gene on Inflammatory Response and Cell Migration in Helicobacter Pylori Infected Gastric Epithelial Cell Line].
4/2013	TRAIL suppresses tumor growth in mice by inducing tumor-infiltrating CD4(+)CD25 (+) Treg apoptosis.
9/2012	A novel anti-DR5 chimeric antibody and epirubicin synergistically suppress tumor growth.
1/2012	2A peptide-based, lentivirus-mediated anti-death receptor 5 chimeric antibody expression prevents tumor growth in nude mice.
3/2011	[Killing effects of controllable expression of tumor necrosis factor-related apoptosis-inducing ligand from mesenchymal stem cells on hepatocellular carcinoma cells].
3/2010	Targeting a novel N-terminal epitope of death receptor 5 triggers tumor cell death.
3/2005	Overexpression of soluble TRAIL induces apoptosis in human lung adenocarcinoma and inhibits growth of tumor xenografts in nude mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Juan Shi Research Topics

Disease

32	Neoplasms (Cancer) 01/2024 - 12/2003
12	Inflammation (Inflammations) 10/2023 - 05/2009
12	Infections 03/2023 - 03/2005
11	Obesity 01/2021 - 01/2012
8	Insulin Resistance 12/2021 - 01/2012
7	Type 2 Diabetes Mellitus (MODY) 09/2023 - 11/2015
6	COVID-19 03/2024 - 01/2021
6	Lung Neoplasms (Lung Cancer) 02/2018 - 03/2005
5	Body Weight (Weight, Body) 10/2023 - 07/2017
4	Weight Loss (Weight Reduction) 10/2023 - 07/2017
4	Fibrosis (Cirrhosis) 01/2023 - 01/2017
4	Stomach Neoplasms (Stomach Cancer) 06/2020 - 03/2016
4	Carcinoma (Carcinomatosis) 01/2019 - 02/2015
4	Pain (Aches) 09/2018 - 05/2003
4	Adenocarcinoma of Lung 02/2018 - 01/2016
3	Cardiovascular Diseases (Cardiovascular Disease) 07/2023 - 01/2012
3	Hyperalgesia 01/2020 - 05/2003
3	Carcinogenesis 01/2019 - 02/2014
3	Lung Diseases (Lung Disease) 01/2018 - 01/2017
3	Rheumatoid Arthritis 11/2016 - 08/2011
2	Virus Diseases (Viral Diseases) 01/2024 - 11/2021
2	Wounds and Injuries (Trauma) 08/2023 - 09/2019
2	Neuroinflammatory Diseases 11/2022 - 08/2017
2	Albuminuria 05/2022 - 05/2017
2	Hypoglycemia (Reactive Hypoglycemia) 01/2022 - 01/2020
2	Aortic Dissection 12/2021 - 03/2020
2	Stroke (Strokes) 03/2020 - 01/2020
2	Hemorrhage 03/2020 - 09/2018
2	Hyperglycemia 01/2020 - 01/2013
2	Cystic Fibrosis (Mucoviscidosis) 01/2018 - 01/2018
2	Chronic Obstructive Pulmonary Disease (COPD) 01/2018 - 01/2017
2	Pneumonia (Pneumonitis) 10/2017 - 01/2017
2	Hypertension (High Blood Pressure) 01/2017 - 02/2016
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2017 - 06/2012
2	Necrosis 09/2016 - 02/2014
2	Parkinson Disease (Parkinson's Disease) 08/2016 - 10/2010
2	Neoplasm Metastasis (Metastasis) 08/2016 - 02/2005
2	Autoimmune Diseases (Autoimmune Disease) 01/2016 - 04/2015
2	Breast Neoplasms (Breast Cancer) 12/2015 - 07/2013
2	Lymphoma (Lymphomas) 02/2015 - 02/2005
2	Leukemia 02/2015 - 03/2009
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 04/2012 - 07/2011
2	Liver Neoplasms (Liver Cancer) 02/2005 - 10/2004
1	Cushing Syndrome 12/2023
1	Endocrine System Diseases (Endocrine Diseases) 12/2023

Drug/Important Bio-Agent (IBA)

10	Glucose (Dextrose)FDA LinkGeneric 10/2023 - 12/2013
10	Proteins (Proteins, Gene)FDA Link 07/2023 - 08/2004
9	VaccinesIBA 03/2024 - 01/2021
8	CytokinesIBA 04/2020 - 04/2013
8	LigandsIBA 03/2016 - 03/2005
7	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2020 - 03/2005
7	TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA 04/2013 - 12/2006
6	CateninsIBA 01/2023 - 06/2014
6	Long Noncoding RNAIBA 04/2020 - 09/2014
6	Death Domain ReceptorsIBA 09/2018 - 03/2009
6	MicroRNAs (MicroRNA)IBA 08/2016 - 07/2013
5	EnzymesIBA 10/2023 - 03/2011
5	Insulin (Novolin)FDA Link 10/2023 - 11/2015
5	AntibodiesIBA 03/2023 - 01/2015
4	Biomarkers (Surrogate Marker)IBA 07/2021 - 01/2016
4	Triglycerides (Triacylglycerol)IBA 01/2021 - 01/2012
3	Broadly Neutralizing AntibodiesIBA 10/2023 - 01/2023
3	Glutamic Acid (Glutamate)FDA Link 11/2022 - 07/2017
3	Analgesics (Analgesic Drugs)IBA 04/2020 - 01/2013
3	Cystic Fibrosis Transmembrane Conductance Regulator (Protein, CFTR)IBA 02/2018 - 01/2018
3	Epirubicin (Ellence)FDA LinkGeneric 09/2012 - 08/2011
2	ImmunosorbentsIBA 10/2023 - 03/2011
2	LipidsIBA 10/2023 - 03/2015
2	Blood Glucose (Blood Sugar)IBA 10/2023 - 01/2020
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2023 - 01/2017
2	Coloring Agents (Dyes)IBA 05/2023 - 03/2016
2	mRNA VaccinesIBA 01/2023 - 10/2022
2	LipopolysaccharidesIBA 11/2022 - 01/2017
2	Antidepressive Agents (Antidepressants)IBA 11/2022 - 08/2017
2	AlbuminsIBA 05/2022 - 05/2017
2	CreatinineIBA 05/2022 - 05/2017
2	Neutralizing AntibodiesIBA 01/2022 - 11/2021
2	RNA (Ribonucleic Acid)IBA 06/2020 - 09/2018
2	InterleukinsIBA 04/2020 - 11/2016
2	TRPC6 Cation ChannelIBA 04/2020 - 07/2006
2	Mitogen-Activated Protein KinasesIBA 09/2018 - 04/2012
2	Toll-Like Receptors (Toll-Like Receptor)IBA 10/2017 - 03/2016
2	Amino Acids FDA Link 07/2017 - 03/2005
2	Cisplatin (Platino)FDA LinkGeneric 04/2017 - 01/2016
2	PlatinumIBA 04/2017 - 06/2012
2	LeptinIBA 01/2017 - 12/2013
2	TNF-Related Apoptosis-Inducing LigandIBA 01/2017 - 01/2012
2	OrexinsIBA 08/2016 - 10/2010
2	HDL CholesterolIBA 03/2015 - 01/2012
2	Janus KinasesIBA 02/2015 - 02/2014
2	AntigensIBA 05/2014 - 03/2011
2	Peptides (Polypeptides)IBA 01/2012 - 11/2010
2	Fatty Acid-Binding ProteinsIBA 01/2012 - 07/2011
1	Hydrocortisone (Cortisol)FDA LinkGeneric 12/2023
1	Adrenocorticotropic Hormone (ACTH)FDA Link 12/2023

Therapy/Procedure

16	Therapeutics 02/2022 - 12/2003
6	Drug Therapy (Chemotherapy) 04/2017 - 12/2003
3	Immunotherapy 01/2024 - 02/2005
2	Glycemic Control 02/2022 - 11/2020
2	Radiotherapy 08/2016 - 12/2003